you are viewing a single comment's thread.
you better cover early mon shorty before this goes to 7
I'm not short. You just need to be realistic in your expectations. This company has had 3 secondaries since going public and all of them at lower prices. $3 million just doesn't go very far when you want to roll out an expensive test for a relatively small population.
Well, I think $20 is VERY realistic, in fact very conservative when you consider the massive market size and what other bios with no products sell for.Thats only a $35 MM market cap.